Breast Diseases

• University Hospital of Crete — Heraklion, Crete, Greece
• University General Hospital of Alexandroupolis, Dep of Medical Oncology — Alexandroupoli, Greece
• "IASO" General Hospital of Athens, 1st Dep of Medical Oncology — Athens, Greece
• "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine — Athens, Greece

Not specified

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States

• Massachusetts General Hospital — Boston, Massachusetts, United States
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• Lowell General Hospital — Lowell, Massachusetts, United States

• Research Site — Oslo, Norway

• NSABP Operations Center — Pittsburgh, Pennsylvania, United States

• University of Washington/Seattle Cancer Care Alliance — Seattle, Washington, United States

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician — Belo Horizonte, BH, Brazil
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician — São Paulo, Brazil
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician — Rio de Janeiro, Brazil
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician — Athens, Greece

• Oncology-Hematology Group of South Florida — Miami, Florida, United States
• Clinical Research Network, Inc. — Plantation, Florida, United States
• Georgia Cancer Specialists — Atlanta, Georgia, United States
• Northwestern University Medical School Division of Hematology/Oncology — Chicago, Illinois, United States